Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
Year: 2020
Type: letter
Abstract: The rapid-acting antidepressant and antisuicidal effects of the anesthetic ( R , S )-ketamine, an N -methyl-d-aspartate receptor (NMDAR) antagonist, is an important discovery in depression research (1). However, the precise molecular mechanisms underlying ( R , S )-ketamine’s antidepressant actions remain unknown. Naltrexone, an opioid receptor antagonist, blocked the rapid antidepressant and antisuicidal effects of ( R , S )-ketamine in treatment-resistant patients with depression (2, 3). Although the sample size was small ( n = 7), the authors concluded that opioid receptor activation is required for the observed ( R , S )-ketamine effects. In contrast, some reports suggest that depressed patients who experience antidepressant effects of ( R , S )-ketamine lack opioid systems (4, 5 …
[↵][1]1Email: hashimoto{at}faculty.chiba-u.jp.
[1]: #xref-corresp-1-1
Author: Kenji Hashimoto
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G2528120606
OpenAlex ID: W3027868414
